Morgan Stanley’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $38.7M | Sell |
1,051,037
-204,650
| -16% | -$7.53M | ﹤0.01% | 2158 |
|
|
2025
Q1 | $44.4M | Buy |
1,255,687
+397,409
| +46% | +$14.1M | ﹤0.01% | 1919 |
|
|
2024
Q4 | $37.5M | Buy |
858,278
+205,460
| +31% | +$8.99M | ﹤0.01% | 2102 |
|
|
2024
Q3 | $29.6M | Sell |
652,818
-342,671
| -34% | -$15.5M | ﹤0.01% | 2395 |
|
|
2024
Q2 | $38.6M | Buy |
995,489
+68,419
| +7% | +$2.66M | ﹤0.01% | 1987 |
|
|
2024
Q1 | $29.9M | Sell |
927,070
-2,379,278
| -72% | -$76.7M | ﹤0.01% | 2251 |
|
|
2023
Q4 | $94.8M | Buy |
3,306,348
+2,504,375
| +312% | +$71.8M | ﹤0.01% | 1784 |
|
|
2023
Q3 | $22.2M | Sell |
801,973
-181,522
| -18% | -$5.02M | ﹤0.01% | 2338 |
|
|
2023
Q2 | $26.3M | Buy |
983,495
+598,758
| +156% | +$16M | ﹤0.01% | 2189 |
|
|
2023
Q1 | $8.33M | Buy |
384,737
+46,761
| +14% | +$1.01M | ﹤0.01% | 3313 |
|
|
2022
Q4 | $8.05M | Buy |
337,976
+86,212
| +34% | +$2.05M | ﹤0.01% | 3284 |
|
|
2022
Q3 | $4.96M | Buy |
251,764
+9,734
| +4% | +$192K | ﹤0.01% | 3702 |
|
|
2022
Q2 | $4.72M | Buy |
242,030
+54,261
| +29% | +$1.06M | ﹤0.01% | 3823 |
|
|
2022
Q1 | $4.79M | Buy |
187,769
+138,843
| +284% | +$3.54M | ﹤0.01% | 3738 |
|
|
2021
Q4 | $1.23M | Sell |
48,926
-51,057
| -51% | -$1.28M | ﹤0.01% | 4922 |
|
|
2021
Q3 | $2.75M | Sell |
99,983
-426,435
| -81% | -$11.7M | ﹤0.01% | 4306 |
|
|
2021
Q2 | $16.7M | Buy |
526,418
+367,073
| +230% | +$11.7M | ﹤0.01% | 2360 |
|
|
2021
Q1 | $7.31M | Buy |
159,345
+129,118
| +427% | +$5.92M | ﹤0.01% | 3000 |
|
|
2020
Q4 | $1.2M | Sell |
30,227
-21,957
| -42% | -$869K | ﹤0.01% | 4562 |
|
|
2020
Q3 | $1.82M | Buy |
52,184
+22,431
| +75% | +$781K | ﹤0.01% | 3743 |
|
|
2020
Q2 | $939K | Sell |
29,753
-17,751
| -37% | -$560K | ﹤0.01% | 4228 |
|
|
2020
Q1 | $1.04M | Buy |
+47,504
| New | +$1.04M | ﹤0.01% | 3918 |
|